About Hologic, Inc.
Hologic, Inc. (HOLX) has been publicly traded since 1990, making it a 36-year-old public company. It operates in the Medical Instruments & Supplies industry within the Healthcare sector. The company is headquartered in Marlborough, United States and employs approximately 7,070 people. With a market capitalization of $17 billion, HOLX is a large established company.
Key Statistics
- Current Price
- $75.12
- Market Cap
- $16.77B
- 52-Week High
- $75.75
- 52-Week Low
- $51.90
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
$1,000 Invested
Monthly Returns Heatmap
Annual Returns
| Year | Return | Start | End |
|---|---|---|---|
| 2026 | +0.85% | $74.49 | $75.12 |
| 2025 | +3.33% | $72.09 | $74.49 |
| 2024 | +0.90% | $71.45 | $72.09 |
| 2023 | -4.49% | $74.81 | $71.45 |
| 2022 | -2.29% | $76.56 | $74.81 |
| 2021 | +5.12% | $72.83 | $76.56 |
| 2020 | +39.49% | $52.21 | $72.83 |
| 2019 | +27.03% | $41.10 | $52.21 |
| 2018 | -3.86% | $42.75 | $41.10 |
| 2017 | +6.56% | $40.12 | $42.75 |
| 2016 | +3.70% | $38.69 | $40.12 |
| 2015 | +44.69% | $26.74 | $38.69 |
| 2014 | +19.64% | $22.35 | $26.74 |
| 2013 | +11.69% | $20.01 | $22.35 |
| 2012 | +14.28% | $17.51 | $20.01 |
| 2011 | -6.96% | $18.82 | $17.51 |
| 2010 | +29.79% | $14.50 | $18.82 |
| 2009 | +10.94% | $13.07 | $14.50 |
| 2008 | -61.92% | $34.32 | $13.07 |
| 2007 | +45.18% | $23.64 | $34.32 |
| 2006 | +24.68% | $18.96 | $23.64 |
| 2005 | +176.08% | $6.87 | $18.96 |
| 2004 | +59.25% | $4.31 | $6.87 |
| 2003 | +41.28% | $3.05 | $4.31 |
| 2002 | +31.43% | $2.32 | $3.05 |
| 2001 | +74.87% | $1.33 | $2.32 |
| 2000 | -7.61% | $1.44 | $1.33 |
| 1999 | -52.58% | $3.03 | $1.44 |
| 1998 | -41.39% | $5.17 | $3.03 |
| 1997 | -16.41% | $6.19 | $5.17 |
| 1996 | +20.73% | $5.12 | $6.19 |
| 1995 | +173.33% | $1.88 | $5.12 |
| 1994 | +242.86% | $0.55 | $1.88 |
| 1993 | -25.53% | $0.73 | $0.55 |
| 1992 | -39.74% | $1.22 | $0.73 |
| 1991 | +8.33% | $1.12 | $1.22 |
Valuation
HOLX currently trades at a trailing P/E ratio of 31.2, which is considered high relative to the broader market. The forward P/E of 15.5 suggests analysts expect earnings to be lower in the coming year. The price-to-book ratio stands at 3.2. The price-to-sales ratio is 4.1.
Dividends
Hologic, Inc. does not currently pay a dividend, choosing to reinvest earnings back into the business for growth.
Risk & Volatility
HOLX has a beta of 0.73, indicating it is less volatile than the overall market. The stock's 52-week range is $51.90 to $75.75, and it currently trades near its 52-week high.
Analyst Ratings
Based on 10 analyst opinions, HOLX has a consensus "hold" rating. The average price target of $76.60 suggests 2.0% upside from current levels.
Frequently Asked Questions
What does Hologic, Inc. do? ▼
Hologic, Inc. is a Medical Instruments & Supplies company operating in the Healthcare sector. The company is headquartered in Marlborough, United States.
What sector is HOLX in? ▼
HOLX operates in the Healthcare sector, specifically in the Medical Instruments & Supplies industry.
When did HOLX go public? ▼
Hologic, Inc. went public in 1990, making it a 36-year-old public company as of 2026.
How much would $1,000 invested in HOLX 5 years ago be worth today? ▼
A $1,000 investment in HOLX five years ago would be worth approximately $1,045 today, representing a 4.5% return.
Does HOLX pay dividends? ▼
No, Hologic, Inc. does not currently pay a dividend. The company reinvests its earnings into growth.
What is HOLX's market cap? ▼
Hologic, Inc. has a market capitalization of $17 billion, classifying it as a large-cap company.
What is HOLX's P/E ratio? ▼
HOLX has a trailing P/E ratio of 31.2 and a forward P/E of 15.5, which measures how much investors are paying per dollar of earnings.
Is HOLX a buy, hold, or sell? ▼
Based on 10 opinions, HOLX has a consensus "hold" rating. The average price target is $76.6.
Last updated: 3/14/2026